<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31577825</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1932-6203</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>PloS one</Title>
          <ISOAbbreviation>PLoS One</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genomic characterisation of perinatal Western Australian Streptococcus agalactiae isolates.</ArticleTitle>
        <Pagination>
          <StartPage>e0223256</StartPage>
          <MedlinePgn>e0223256</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0223256</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0223256</ELocationID>
        <Abstract>
          <AbstractText>As a leading cause of neonatal sepsis, Streptococcus agalactiae, commonly known as Group B Streptococcus, is a major neonatal pathogen. Current global screening practices employ risk- or culture-based protocols for detection of these organisms. In Western Australia (WA), universal culture-based screening is provided, with subsequent intrapartum antibiotic prophylaxis for all S. agalactiae-positive women during labour. Widespread antibiotic exposure is not ideal and this is one of the factors driving development of vaccines against S. agalactiae. Vaccine candidates have focused on the capsule, surface proteins and pilus types, however, capsule serotypes are known to vary geographically. The aim of this study was to use genome sequencing to gain an understanding of the circulating genotypes in WA, and to assess variations in the associated gene pools. We sequenced 141 antenatal carriage (vaginal/rectal) isolates and 10 neonatal invasive disease isolates from WA. Based on the global PubMLST database, the 151 strains were characterised into 30 sequence types, with clustering of these mainly into clonal complexes 1, 12, 17, 19 and 23. Of the genes encoding eleven surface proteins that were analysed, the most prevalent were fbp, lmb and scpB which were present in ≥ 98% of isolates. A cluster of non-haemolytic isolates, one of which was a neonatal invasive disease isolate, appeared to lack the entire cyl locus. Admixture analysis of population structure revealed evidence of genetic transfer among the WA isolates across structural groups. When compared against the PubMLST S. agalactiae data, WA isolates showed high levels of strain diversity with minimal apparent clustering. This is the first whole genome sequence study of WA S. agalactiae isolates and also represents the first addition of Australian isolate data to PubMLST. This report provides insight into the distribution and diversity of vaccine targets of S. agalactiae within Western Australia, indicating that the most appropriate capsular vaccine for this population would be the proposed pentavalent (Cps Ia, Ib, II, III and V) preparation, whilst vaccines targeting surface proteins should ideally utilise Fbp, Lmb and/or ScpB.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Furfaro</LastName>
            <ForeName>Lucy L</ForeName>
            <Initials>LL</Initials>
            <Identifier Source="ORCID">0000-0001-7652-0713</Identifier>
            <AffiliationInfo>
              <Affiliation>The School of Medicine, Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Barbara J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The Marshall Centre for Infectious Diseases Research and Training, The University of Western Australia, Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kahler</LastName>
            <ForeName>Charlene M</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Biomedical Sciences, The Marshall Centre for Infectious Diseases Research and Training, The University of Western Australia, Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Payne</LastName>
            <ForeName>Matthew S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>The School of Medicine, Division of Obstetrics and Gynaecology, The University of Western Australia, Perth, Western Australia, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>02</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS One</MedlineTA>
        <NlmUniqueID>101285081</NlmUniqueID>
        <ISSNLinking>1932-6203</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D005798" MajorTopicYN="N">Genes, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="Y">Genome, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018743" MajorTopicYN="Y">Perinatal Care</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013292" MajorTopicYN="N">Streptococcus agalactiae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014904" MajorTopicYN="N" Type="Geographic">Western Australia</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31577825</ArticleId>
        <ArticleId IdType="pmc">PMC6774530</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pone.0223256</ArticleId>
        <ArticleId IdType="pii">PONE-D-19-18263</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Verani JR, McGee L, Schrag SJ (2010) Prevention of perinanatal group B streptococcal disease: revised guidelines from CDC, 2010. Recommendations and Reports
59: 1–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21088663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. (2017) Maternal colonization with group B Streptococcus and serotype distribution worldwide: Systematic review and meta-analyses. Clinical Infectious Diseases
65: S100–S111. 10.1093/cid/cix658
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix658</ArticleId>
            <ArticleId IdType="pmc">PMC5848259</ArticleId>
            <ArticleId IdType="pubmed">29117327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO, et al. (2014) Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis
14: 323
10.1186/1471-2334-14-323
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-14-323</ArticleId>
            <ArticleId IdType="pmc">PMC4061772</ArticleId>
            <ArticleId IdType="pubmed">24919844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furfaro LL, Nathan EA, Chang BJ, Payne MS (2019) Group B streptococcus prevalence, serotype distribution and colonization dynamics in Western Australian pregnant women. Journal of Medical Microbiology.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31013212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, et al. (2008) Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol
46: 1285–1291. 10.1128/JCM.02105-07
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02105-07</ArticleId>
            <ArticleId IdType="pmc">PMC2292926</ArticleId>
            <ArticleId IdType="pubmed">18287314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, et al. (2012) Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis
206: 1745–1752. 10.1093/infdis/jis605
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jis605</ArticleId>
            <ArticleId IdType="pubmed">23002446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins ER, Melo-Cristino J, Ramirez M (2010) Evidence for rare capsular switching in Streptococcus agalactiae. J Bacteriol
192: 1361–1369. 10.1128/JB.01130-09
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01130-09</ArticleId>
            <ArticleId IdType="pmc">PMC2820851</ArticleId>
            <ArticleId IdType="pubmed">20023016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meehan M, Cunney R, Cafferkey M (2014) Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching. Eur J Clin Microbiol Infect Dis
33: 1155–1162. 10.1007/s10096-014-2055-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2055-5</ArticleId>
            <ArticleId IdType="pubmed">24469423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neemuchwala A, Teatero S, Athey TB, McGeer A, Fittipaldi N (2016) Capsular switching and other large-scale recombination events in invasive sequence type 1 group B Streptococcus. Emerg Infect Dis
22: 1941–1944. 10.3201//eid2211.152064
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201//eid2211.152064</ArticleId>
            <ArticleId IdType="pmc">PMC5088006</ArticleId>
            <ArticleId IdType="pubmed">27767925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong F, Lambertsen LM, Slotved HC, Ko D, Wang H, Gilbert GL (2008) Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci. J Clin Microbiol
46: 2745–2750. 10.1128/JCM.00189-08
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00189-08</ArticleId>
            <ArticleId IdType="pmc">PMC2519501</ArticleId>
            <ArticleId IdType="pubmed">18562579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, et al. (2013) Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol
51: 503–507. 10.1128/JCM.02417-12
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02417-12</ArticleId>
            <ArticleId IdType="pmc">PMC3553911</ArticleId>
            <ArticleId IdType="pubmed">23196363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furfaro LL, Chang BJ, Payne MS (2018) Perinatal Streptococcus agalactiae epidemiology and surveillance targets. Clinical Microbiology Reviews
31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6148196</ArticleId>
            <ArticleId IdType="pubmed">30111577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, et al. (1999) Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis
179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10068604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, et al. (2003) Multilocus sequence typing system for group B streptococcus. J Clin Microbiol
41: 2530–2536. 10.1128/JCM.41.6.2530-2536.2003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.41.6.2530-2536.2003</ArticleId>
            <ArticleId IdType="pmc">PMC156480</ArticleId>
            <ArticleId IdType="pubmed">12791877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, et al. (2014) Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun
5: 4544
10.1038/ncomms5544
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms5544</ArticleId>
            <ArticleId IdType="pmc">PMC4538795</ArticleId>
            <ArticleId IdType="pubmed">25088811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furfaro LL, Chang BJ, Payne MS (2017) A novel one-step real-time multiplex PCR assay to detect Streptococcus agalactiae presence and serotypes Ia, Ib, and III. Diagnostic Microbiology and Infectious Disease
89: 7–12. 10.1016/j.diagmicrobio.2017.06.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.06.003</ArticleId>
            <ArticleId IdType="pubmed">28669679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inouye M, Dashnow H, Raven LA, Schultz MB, Pope BJ, Tomita T, et al. (2014) SRST2: Rapid genomic surveillance for public health and hospital microbiology labs. Genome Med
6: 90
10.1186/s13073-014-0090-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13073-014-0090-6</ArticleId>
            <ArticleId IdType="pmc">PMC4237778</ArticleId>
            <ArticleId IdType="pubmed">25422674</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jolley KA, Maiden MC (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics
11: 595
10.1186/1471-2105-11-595
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-11-595</ArticleId>
            <ArticleId IdType="pmc">PMC3004885</ArticleId>
            <ArticleId IdType="pubmed">21143983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol
19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3342519</ArticleId>
            <ArticleId IdType="pubmed">22506599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurevich A, Saveliev V, Vyahhi N, Tesler G (2013) QUAST: quality assessment tool for genome assemblies. Bioinformatics
29: 1072–1075. 10.1093/bioinformatics/btt086
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btt086</ArticleId>
            <ArticleId IdType="pmc">PMC3624806</ArticleId>
            <ArticleId IdType="pubmed">23422339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kapatai G, Patel D, Efstratiou A, Chalker VJ (2017) Comparison of molecular serotyping approaches of Streptococcus agalactiae from genomic sequences. BMC Genomics
18: 429
10.1186/s12864-017-3820-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-017-3820-5</ArticleId>
            <ArticleId IdType="pmc">PMC5455115</ArticleId>
            <ArticleId IdType="pubmed">28571573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creti R, Fabretti F, Orefici G, von Hunolstein C (2004) Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes. J Clin Microbiol
42: 1326–1329. 10.1128/JCM.42.3.1326-1329.2004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.42.3.1326-1329.2004</ArticleId>
            <ArticleId IdType="pmc">PMC356896</ArticleId>
            <ArticleId IdType="pubmed">15004110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corander J, Marttinen P, Sirén J, Tang J (2008) Enhanced Bayesian modelling in BAPS software for learning genetic structures of populations. BMC Bioinformatics
9: 539
10.1186/1471-2105-9-539
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-9-539</ArticleId>
            <ArticleId IdType="pmc">PMC2629778</ArticleId>
            <ArticleId IdType="pubmed">19087322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L, Connor TR, Siren J, Aanensen DM, Corander J (2013) Hierarchical and spatially explicit clustering of DNA sequences with BAPS software. Mol Biol Evol
30: 1224–1228. 10.1093/molbev/mst028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/mst028</ArticleId>
            <ArticleId IdType="pmc">PMC3670731</ArticleId>
            <ArticleId IdType="pubmed">23408797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seale AC, Koech AC, Sheppard AE, Barsosio HC, Langat J, Anyango E, et al. (2016) Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol
1: 16067
10.1038/nmicrobiol.2016.67
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmicrobiol.2016.67</ArticleId>
            <ArticleId IdType="pmc">PMC4936517</ArticleId>
            <ArticleId IdType="pubmed">27572968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flores AR, Galloway-Pena J, Sahasrabhojane P, Saldana M, Yao H, Su X, et al. (2015) Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes. Proc Natl Acad Sci U S A
112: 6431–6436. 10.1073/pnas.1504725112
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1504725112</ArticleId>
            <ArticleId IdType="pmc">PMC4443349</ArticleId>
            <ArticleId IdType="pubmed">25941374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teatero S, McGeer A, Low DE, Li A, Demczuk W, Martin I, et al. (2014) Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol
52: 1441–1447. 10.1128/JCM.03554-13
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.03554-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993709</ArticleId>
            <ArticleId IdType="pubmed">24554752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehershahi KS, Hsu LY, Koh TH, Chen SL (2015) Complete genome sequence of Streptococcus agalactiae serotype III, multilocus sequence type 283 strain SG-M1. Genome Announc
3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4616172</ArticleId>
            <ArticleId IdType="pubmed">26494662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh P, Springman AC, Davies HD, Manning SD (2012) Whole-genome shotgun sequencing of a colonizing multilocus sequence type 17 Streptococcus agalactiae strain. J Bacteriol
194: 6005
10.1128/JB.01378-12
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01378-12</ArticleId>
            <ArticleId IdType="pmc">PMC3486095</ArticleId>
            <ArticleId IdType="pubmed">23045509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S, Stecher G, Tamura K (2016) MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular Biology and Evolution
33: 1870–1874. 10.1093/molbev/msw054
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/msw054</ArticleId>
            <ArticleId IdType="pmc">PMC8210823</ArticleId>
            <ArticleId IdType="pubmed">27004904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letunic I, Bork P (2016) Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res
44: W242–245. 10.1093/nar/gkw290
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw290</ArticleId>
            <ArticleId IdType="pmc">PMC4987883</ArticleId>
            <ArticleId IdType="pubmed">27095192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SM, Zhi Y, Ahn KB, Lim S, Seo HS (2018) Status of group B streptococcal vaccine development. Clin Exp Vaccine Res
7: 76–81. 10.7774/cevr.2018.7.1.76
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7774/cevr.2018.7.1.76</ArticleId>
            <ArticleId IdType="pmc">PMC5795048</ArticleId>
            <ArticleId IdType="pubmed">29399583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heath PT (2016) Status of vaccine research and development of vaccines for GBS. Vaccine
34: 2876–2879. 10.1016/j.vaccine.2015.12.072
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.12.072</ArticleId>
            <ArticleId IdType="pubmed">26988258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Doare K, Heath PT (2013) An overview of global GBS epidemiology. Vaccine
31
Suppl 4: D7–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23973349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, et al. (2017) Infant group B Streptococcal disease incidence and serotypes worldwide: Systematic review and meta-analyses. Clinical Infectious Diseases
65: S160–S172. 10.1093/cid/cix656
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix656</ArticleId>
            <ArticleId IdType="pmc">PMC5850457</ArticleId>
            <ArticleId IdType="pubmed">29117326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eskandarian N, Ismail Z, Neela V, van Belkum A, Desa MN, Amin Nordin S (2015) Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients.
Eur J Clin Microbiol Infect Dis
34: 579–584. 10.1007/s10096-014-2265-x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2265-x</ArticleId>
            <ArticleId IdType="pmc">PMC4356882</ArticleId>
            <ArticleId IdType="pubmed">25359580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suhaimi MES, Desa MNM, Eskandarian N, Pillay SG, Ismail Z, Neela VK, et al. (2017) Characterization of a Group B Streptococcus infection based on the demographics, serotypes, antimicrobial susceptibility and genotypes of selected isolates from sterile and non-sterile isolation sites in three major hospitals in Malaysia.
J Infect Public Health
10: 14–21. 10.1016/j.jiph.2016.01.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2016.01.009</ArticleId>
            <ArticleId IdType="pubmed">27095302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor K (2006) A study of group B streptococcus in Brisbane: the epidemiology, detection by PCR assay and serovar prevalence. Masters Thesis.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhao Z, Kong F, Zeng X, Gidding HF, Morgan J, Gilbert GL (2008) Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin Microbiol Infect
14: 260–267. 10.1111/j.1469-0691.2007.01914.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2007.01914.x</ArticleId>
            <ArticleId IdType="pubmed">18190584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X, Kong F, Wang H, Darbar A, Gilbert GL (2006) Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother
50: 204–209. 10.1128/AAC.50.1.204-209.2006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.50.1.204-209.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1346803</ArticleId>
            <ArticleId IdType="pubmed">16377687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL (2007) Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol
45: 2929–2936. 10.1128/JCM.00117-07
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00117-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045254</ArticleId>
            <ArticleId IdType="pubmed">17634306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ko DW, Zurynski Y, Gilbert GL (2015) Group B streptococcal disease and genotypes in Australian infants. J Paediatr Child Health.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25656648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudjonsdottir MJ, Hentz E, Berg S, Backhaus E, Elfvin A, Kawash S, et al. (2015) Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988. BMC Infect Dis
15: 507
10.1186/s12879-015-1266-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-015-1266-4</ArticleId>
            <ArticleId IdType="pmc">PMC4640215</ArticleId>
            <ArticleId IdType="pubmed">26553333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, et al. (2007) Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among Group B Streptococci in Italy. Journal of Clinical Microbiology
45: 2909–2916. 10.1128/JCM.00999-07
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00999-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045288</ArticleId>
            <ArticleId IdType="pubmed">17634303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hery-Arnaud G, Bruant G, Lanotte P, Brun S, Picard B, Rosenau A, et al. (2007) Mobile genetic elements provide evidence for a bovine origin of clonal complex 17 of Streptococcus agalactiae. Appl Environ Microbiol
73: 4668–4672. 10.1128/AEM.02604-06
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02604-06</ArticleId>
            <ArticleId IdType="pmc">PMC1932819</ArticleId>
            <ArticleId IdType="pubmed">17526784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lartigue MF, Hery-Arnaud G, Haguenoer E, Domelier AS, Schmit PO, van der Mee-Marquet N, et al. (2009) Identification of Streptococcus agalactiae isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol
47: 2284–2287. 10.1128/JCM.00175-09
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00175-09</ArticleId>
            <ArticleId IdType="pmc">PMC2708490</ArticleId>
            <ArticleId IdType="pubmed">19403759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M (2005) Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol
43: 3727–3733. 10.1128/JCM.43.8.3727-3733.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.8.3727-3733.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1233917</ArticleId>
            <ArticleId IdType="pubmed">16081902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Mee-Marquet N, Fourny L, Arnault L, Domelier AS, Salloum M, Lartigue MF, et al. (2008) Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites. J Clin Microbiol
46: 2906–2911. 10.1128/JCM.00421-08
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00421-08</ArticleId>
            <ArticleId IdType="pmc">PMC2546740</ArticleId>
            <ArticleId IdType="pubmed">18632904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P (2010) Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol
48: 3100–3104. 10.1128/JCM.00277-10
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00277-10</ArticleId>
            <ArticleId IdType="pmc">PMC2937746</ArticleId>
            <ArticleId IdType="pubmed">20610684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campisi E, Rinaudo CD, Donati C, Barucco M, Torricelli G, Edwards MS, et al. (2016) Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages. Sci Rep
6: 29799
10.1038/srep29799
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep29799</ArticleId>
            <ArticleId IdType="pmc">PMC4944191</ArticleId>
            <ArticleId IdType="pubmed">27411639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lyhs U, Kulkas L, Katholm J, Waller KP, Saha K, Tomusk RJ, et al. (2016) Streptococcus agalactiae serotype IV in humans and cattle, Northern Europe. Emerg Infect Dis
22: 2097–2103. 10.3201/eid2212.151447
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2212.151447</ArticleId>
            <ArticleId IdType="pmc">PMC5189126</ArticleId>
            <ArticleId IdType="pubmed">27869599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florindo C, Damiao V, Silvestre I, Farinha C, Rodrigues F, Nogueira F, et al. (2014) Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone. Euro Surveill
19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24957747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrieri P, Lynfield R, Creti R, Flores AE (2013) Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000–2010. Emerg Infect Dis
19: 551–558. 10.3201/eid1904.121572
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1904.121572</ArticleId>
            <ArticleId IdType="pmc">PMC3647718</ArticleId>
            <ArticleId IdType="pubmed">23628320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teatero S, McGeer A, Li A, Gomes J, Seah C, Demczuk W, et al. (2015) Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada. Emerg Infect Dis
21: 585–591. 10.3201/eid2014.140759
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2014.140759</ArticleId>
            <ArticleId IdType="pmc">PMC4378482</ArticleId>
            <ArticleId IdType="pubmed">25811284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dangor Z, Kwatra G, Izu A, Adrian P, Cutland CL, Velaphi S, et al. (2015) Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines
14: 1651–1660. 10.1586/14760584.2015.1085307
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.2015.1085307</ArticleId>
            <ArticleId IdType="pubmed">26364978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson C, Lindroth M, Nordin P, Stalhammar-Carlemalm M, Lindahl G, Krantz I (2006) Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection. Arch Dis Child Fetal Neonatal Ed
91: F403–408. 10.1136/adc.2005.090472
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.2005.090472</ArticleId>
            <ArticleId IdType="pmc">PMC2672751</ArticleId>
            <ArticleId IdType="pubmed">17056838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong F, Gowan S, Martin D, James G, Gilbert GL (2002) Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J Clin Microbiol
40: 620–626. 10.1128/JCM.40.2.620-626.2002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.40.2.620-626.2002</ArticleId>
            <ArticleId IdType="pmc">PMC153396</ArticleId>
            <ArticleId IdType="pubmed">11825981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Granger J, Spellerberg B, Asam D, Rosa-Fraile M (2015) Non-haemolytic &amp; non-pigmented group B streptococcus, an infrequent cause of early onset neonatal sepsis. Pathogens and Disease.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4626576</ArticleId>
            <ArticleId IdType="pubmed">26449711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Six A, Firon A, Plainvert C, Caplain C, Bouaboud A, Touak G, et al. (2016) Molecular characterization of nonhemolytic and nonpigmented Group B Streptococci responsible for human invasive infections. J Clin Microbiol
54: 75–82. 10.1128/JCM.02177-15
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02177-15</ArticleId>
            <ArticleId IdType="pmc">PMC4702713</ArticleId>
            <ArticleId IdType="pubmed">26491182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gendrin C, Vornhagen J, Armistead B, Singh P, Whidbey C, Merillat S, et al. (2017) A non-hemolytic Group B Streptococcus strain exhibits hypervirulence. The Journal of Infectious Diseases: jix646-jix646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5853813</ArticleId>
            <ArticleId IdType="pubmed">29244079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herbert MA, Beveridge CJ, Saunders NJ (2004) Bacterial virulence factors in neonatal sepsis: group B streptococcus. Curr Opin Infect Dis
17: 225–229. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15166825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu GY, Nizet V (2004) Extracellular virulence factors of group B Streptococci. Front Biosci
9: 1794–1802. 10.2741/1296
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2741/1296</ArticleId>
            <ArticleId IdType="pubmed">14977587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajagopal L (2009) Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol
4: 201–221. 10.2217/17460913.4.2.201
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/17460913.4.2.201</ArticleId>
            <ArticleId IdType="pmc">PMC2691590</ArticleId>
            <ArticleId IdType="pubmed">19257847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milligan TW, Baker CJ, Straus DC, Mattingly SJ (1978) Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun
21: 738–746. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC422060</ArticleId>
            <ArticleId IdType="pubmed">361576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Granlund M, Oberg L, Sellin M, Norgren M (1998) Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. J Infect Dis
177: 967–976. 10.1086/515233
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/515233</ArticleId>
            <ArticleId IdType="pubmed">9534970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS (2011) Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol
193: 6834–6842. 10.1128/JB.00094-11
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00094-11</ArticleId>
            <ArticleId IdType="pmc">PMC3232834</ArticleId>
            <ArticleId IdType="pubmed">21984789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rinaudo CD, Rosini R, Galeotti CL, Berti F, Necchi F, Reguzzi V, et al. (2010) Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus. PLoS One
5: e9216
10.1371/journal.pone.0009216
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0009216</ArticleId>
            <ArticleId IdType="pmc">PMC2821406</ArticleId>
            <ArticleId IdType="pubmed">20169161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazzarin M, Mu R, Fabbrini M, Ghezzo C, Rinaudo CD, Doran KS, et al. (2017) Contribution of pilus type 2b to invasive disease caused by a Streptococcus agalactiae ST-17 strain. BMC Microbiology
17: 148
10.1186/s12866-017-1057-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12866-017-1057-8</ArticleId>
            <ArticleId IdType="pmc">PMC5496222</ArticleId>
            <ArticleId IdType="pubmed">28673237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Springman AC, Lacher DW, Waymire EA, Wengert SL, Singh P, Zadoks RN, et al. (2014) Pilus distribution among lineages of group b streptococcus: an evolutionary and clinical perspective. BMC Microbiol
14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4074840</ArticleId>
            <ArticleId IdType="pubmed">24943359</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
